Abaloparatide

Records for this ingredient, by country (identity only).

ATC H05AA04 · 4 markets · 7 records

Abaloparatide 4 markets · 7 records Forms
Filters

AU 3 records · 2 shown of 2 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 2 mg/1 mLinjectionEladynos
  • 2 mg/mL per mL / per unit basis not statedinjectionELADYNOS abaloparatide 2 mg/mL solution for injection cartridge in a pre-filled pen unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

EU 2 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength · includes records with unknown status (not proof of sale)

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

  • 3.12 mg/1.56 mLinjectionTymlos

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 1.5 mL per mL / per unit basis not statedinjectionEladynos 80micrograms/40microlitres solution for injection 1.5ml pre-filled pens

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.